Methods and compositions for treating neoplasms

Details Methods and compositions for treating neoplasms Methods and compositions for treating neoplasms

2005-12-20

2005-12-20

Meller, Michael (Department: 1655)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Reexamination Certificate

active

06977169

ABSTRACT:
The present invention comprises the periodic administration of a solution of neuraminidase to a patient with a neoplasm until the neoplasm has receded. The administration of the solution of neuraminidase can be administered by subcutaneous injection, intramuscular injection, intravenous injection, nasal administration, sublingual administration or transdermal administration. The present invention is effective in treating a wide variety of neoplasms.

REFERENCES:
patent: 3792159 (1974-02-01), Green et al.
patent: 5558863 (1996-09-01), Kline et al.
patent: 5736133 (1998-04-01), Kline et al.
Watkins, Jr. et al., Int. J. Cancer, 14, 799-807, 1974.
Sedlacek et al., Int. J. Immunopharmacol. , 9 (7), 1987, 841-50.
Sedlacek et al., Cancer Immunol. Immunother 23 (3), 1986 192-199.
Maiskii et al., Byull eksp biol med 84 (12) 1977 (recd 1978) 714-717.
Knop et al., Immunology, 34 (2), 1978, 181-188.
Gautam et al., Indian J. Med Res 64 (3), 1976 472-481.
Sedlacek et al., Cancer Immunology Immunotherapy (cancer immunol. Immunother.) May 3, 1978 153-163.
Mobley et al., Res. Commun. Chem. Path. Pharmacol. Sep. 1, 1974 155-162.
Gorman, Time Magazine, May 18, 1998, pp. 38-46.
Tain, Cancer and Metastatis Reviews, p: 253-66, 1996.
Tain, Science, vol. 271, Feb. 1996, pp. 1079-1080.
Devmer, Bio/Technology, vol. 12, 1994, p. 320.
Y Gura, Science, vol. 278, 1997, pp. 1041-1042.
Sedlacek, H. H. et al., Tumor Therapy of Neoplastic Disease with Tumor Cells and Neuraminidase: Experimental Studies on Chessboard Vaccination in Transplantation Tumors, Int. J. Immunophamac., 1987, pp. 841-850, vol. 9, No. 7.
Mobley, James R. et al., “Phytomitogen and Meuraminidase in the Treatment of Ehrlich Carcinoma in Mice”, Research Communications in Chemical Pathology and Phamacology, Sep.-Dec. 1974, pp. 155-162, vol. 9, No. 1.
Gautam, Savita and Alkat, B.K., “Immuno-therapy of Methyl Cholanthrene Induced and Spontaneous Tumors in Mice by Use of Tumor Vaccine, Neuraminidase and BCG”, Indian J Med Res, Mar. 1976, pp. 472-481, vol. 64, No. 3.
Sedlacek, H.H. et al., “Tumor Therpay of Neoplastic Disease with Tumor Cells and Neuraminidase”, Cancer Immunology and Immunotherapy, 1996, pp. 192-199, vol. 23, No. 1.
Sedkacek, H.H. and Seiler, F.R., “Immunotherapy of Neoplastic Diseases with Neuraminidase: Contradictions, New Aspects, and Revised Concepts”, Cancer Immunology and Immunotherapy, 1978, pp. 153-163, vol. 5.
Knop, J. et al., “Stimulatory Effect ofVibrio choleraeNeuraminidase on the Antibody Response to Various Antigens”, Immunology, 1978, pp. 181-187, vol. 34.
Simmons, R., et al.,“Regression of Established Methylcholanthrene Tumors by Intratumor Injections ofVibrio choleraeNeuraminidase,”Journal of Surgical Onicology, vol. 4, No. 4, pp. 298-305 (1972).
Simmons, R., et al., “Immunospecific Regression of Methylcholanthrene Fibrosarcoma With The Use of Neuraminidase. II. Intratumor Injections of Neuraminidase,”Surgery, vol. 71, No. 4, pp. 556-564 (1972).

Affiliated with

Also associated with

Rating

Methods and compositions for treating neoplasms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for treating neoplasms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating neoplasms will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3488513